000151487 001__ 151487
000151487 005__ 20251017144625.0
000151487 0247_ $$2doi$$a10.3390/ani11102790
000151487 0248_ $$2sideral$$a126545
000151487 037__ $$aART-2021-126545
000151487 041__ $$aeng
000151487 100__ $$aGómez Ochoa, P.
000151487 245__ $$aUltrasound-guided radiofrequency ablation of chemodectomas in five dogs
000151487 260__ $$c2021
000151487 5060_ $$aAccess copy available to the general public$$fUnrestricted
000151487 5203_ $$aChemodectomas are low prevalence tumors with complex clinical management. Many present as an incidental finding however, in other dogs, they produce pericardial effusion and/or compression, leading to the appearance of severe clinical signs. There are currently several ap-proaches: surgery, radiotherapy, stent placement and chemotherapy. This is the first description of percutaneous echo-guided radiofrequency ablation of aortic body tumors. This minimally invasive treatment is based on high frequency alternating electrical currents from an electrode that produces ionic agitation and generates frictional heat, causing coagulation necrosis. Five dogs with an echo-cardiographic and cytological diagnosis of chemodectoma underwent percutaneous echo-guided radiofrequency ablation. At the time of presentation, all the dogs showed clinical signs, such as ascites and/or collapse. There were no complications either during the procedure or in the following 24 hours. Rapid clinical improvement associated with a reduction in size and change in sonographic appearance of the mass were achieved with no complications. Six months follow-up was carried out in all dogs. A second percutaneous echo-guided RFA was performed eight months after the first procedure in one dog. Based on our experience, radiofrequency ablation seems to be a feasible and safe technique, making it a potential alternative therapeutic approach in the clinical management of aortic body tumors leading to severe clinical compromise.
000151487 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000151487 590__ $$a3.231$$b2021
000151487 591__ $$aVETERINARY SCIENCES$$b16 / 145 = 0.11$$c2021$$dQ1$$eT1
000151487 591__ $$aAGRICULTURE, DAIRY & ANIMAL SCIENCE$$b13 / 62 = 0.21$$c2021$$dQ1$$eT1
000151487 592__ $$a0.61$$b2021
000151487 593__ $$aVeterinary (miscellaneous)$$c2021$$dQ1
000151487 593__ $$aAnimal Science and Zoology$$c2021$$dQ1
000151487 594__ $$a2.7$$b2021
000151487 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000151487 700__ $$aAlférez, M.D.
000151487 700__ $$0(orcid)0000-0002-1204-4356$$aBlas, I. de$$uUniversidad de Zaragoza
000151487 700__ $$aFernendes, T.
000151487 700__ $$aSánchez Salguero, X.
000151487 700__ $$aBalañá, B.
000151487 700__ $$aMeléndez Lazo, A.
000151487 700__ $$aBarbero Fernandez, A.
000151487 700__ $$aCaivano, D.
000151487 700__ $$aCorda, F.
000151487 700__ $$aCorda, A.
000151487 7102_ $$11009$$2773$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Sanidad Animal
000151487 773__ $$g11, 10 (2021), 2790 [12 pp.]$$pAnimals (Basel)$$tAnimals$$x2076-2615
000151487 8564_ $$s1340222$$uhttps://zaguan.unizar.es/record/151487/files/texto_completo.pdf$$yVersión publicada
000151487 8564_ $$s2908236$$uhttps://zaguan.unizar.es/record/151487/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000151487 909CO $$ooai:zaguan.unizar.es:151487$$particulos$$pdriver
000151487 951__ $$a2025-10-17-14:23:32
000151487 980__ $$aARTICLE